Valuation
LTGOLatigo Biotherapeutics Inc.
StockNasdaqUnited StatesHealth careEU retail: available
+4.1% today
No score: too little data.
No dividend.
Ratios vs sector
Medians of Health care companies in the same region (stocks and REITs).
| Metric | LTGO | Sector median | vs median |
|---|---|---|---|
| P/E | — | 30.6 · n=152 | — |
| P/B | — | 4.0 · n=305 | — |
| P/S | — | 4.4 · n=297 | — |
| EV/EBIT | — | 25.8 · n=139 | — |
| Free-cash-flow yield | — | 1.4% · n=287 | — |
| Dividend yield | 0.00% | 0.00% · n=358 | — |
| Return on equity | — | −3.7% · n=306 | — |
| Return on invested capital | — | 0.4% · n=275 | — |
| Gross margin | — | 61.7% · n=202 | — |
| Net debt / EBITDA | — | 1.31 · n=146 | — |
Sector peers
The largest companies of the same sector and region.
| LLYEli Lilly & Co | 45.4 | 35.8 | — | 1.5% | 0.6% | 7/10 |
|---|---|---|---|---|---|---|
| JNJJohnson & Johnson | 40.5 | 8.0 | — | 3.2% | 1.9% | 8/10 |
| ABBVAbbVie | 80.6 | — | 33.8 | 3.6% | 3.0% | 5/10 |
| UNHUnitedHealth | 25.9 | 3.5 | 19.1 | 6.5% | 2.2% | 9/10 |
| MRKMerck | 109.6 | 8.3 | — | 4.6% | 2.4% | 9/10 |
| TMOThermo Fisher Scientific | 37.4 | 4.9 | 36.7 | 2.8% | 0.3% | 10/10 |
| AMGNAmgen | 27.9 | 20.9 | 25.2 | 4.2% | 2.2% | 7/10 |
| GILDGILEAD | — | 16.7 | — | 6.6% | 2.0% | 5/10 |
| ABTAbbott | 28.4 | 3.4 | 26.8 | 4.1% | 3.0% | 6/10 |
| PFEPfizer | 38.7 | 2.0 | — | 6.5% | 7.3% | 1/10 |
Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 31 Dec 2025 · filed 03 Sep 2026
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.